Maheshwari Anshul sold $94K of SIBN
Maheshwari Anshul (Chief Op & Financial Officer) sold 5,049 shares of SI-BONE, Inc. (SIBN) at an average of $18.63 ($18.17–$19.50) across 3 trades over 2026-10-02 to 2026-10-05 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosed sale is modest in size relative to the insider's remaining holdings, suggesting limited market impact.
Market read
A small insider sell may cause slight short‑term pressure but is unlikely to drive significant price movement.
What to watch
Potential tax planning or portfolio rebalancing motives may drive the sale rather than operational concerns.
Background
Form 4 filings disclose insider transactions; investors monitor them for signals about management confidence.
Ticker impact
Chief Operating & Financial Officer sold 5,049 shares for $94K via a 10b5-1 plan, reducing his stake to 218,235 shares.
likely modest downward pressure as the market prices the insider sell.
A C-suite insider sold shares worth under $100K, a modest amount that may be viewed as a slight negative signal but unlikely to move the stock dramatically.
Market effects
Minimal impact on the orthopedic device sector; no broader industry signal.
Limited to U.S. investors tracking SI-BONE.
Low; the transaction is company‑specific.
Counterpoint
The sale could be routine under a pre‑arranged 10b5‑1 plan, not reflecting any lack of confidence.
Key entities
- OfficerMaheshwari Anshul
Chief Operating & Financial Officer of SI‑BONE, Inc.
